Refractory hyperkalaemia associated with trimethoprim-sulfamethoxazole therapy in neutropaenic sepsis
Author(s) -
Manoj Edirisooriya Maddumage,
Atapattuge Yamini Anuchana Gunasekara,
Waruni Rangika Samaranayake
Publication year - 2017
Publication title -
sri lankan journal of anaesthesiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 4
eISSN - 2279-1965
pISSN - 1391-8834
DOI - 10.4038/slja.v25i2.8250
Subject(s) - medicine , sri lanka , scopus , audit , sulfamethoxazole , trimethoprim , sepsis , family medicine , intensive care medicine , medline , surgery , south asia , management , ethnology , microbiology and biotechnology , biology , political science , law , economics , history , antibiotics
Hyperkalaemia is a potentially life threatening electrolyte disorder commonly seen in critically ill patients secondary to renal impairment. Herein, we report a case of severe hyperkalaemia, which was disproportionate to the degree of renal impairment, associated with neutropaenic sepsis, in a critically ill middle aged gentleman. Hyperkalaemia was refractory to medical treatment necessitating haemodialysis in the background of recent administration of trimethoprim- sulfamethoxazole (TMX-SMX) for presumed pneumocystis jiroveci pneumonia. It is important for clinicians to be aware of this complication as TMX-SMX is a popular antibiotic in immunocompromised populations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom